Pharmacological Hypogonadotropism Can be Used to Advantage for Ovulation Induction Protocols
Ovarian stimulation with hMG/hCG is an established therapeutic principle in anovulatory patients with amenorrhea, low gonadotropins and a negligible endogenous estrogen production. Exogenous gonadotropins are also used for ovarian stimulation in women who are not typical candidates for this type of treatment, i.e. those with anovulatory cycles and in cases of luteal insufficiency which do not respond to clomiphene. In addition, exogenous gonadotropins are given to patients who are to be prepared for intrauterine insemination, in vitro fertilization (IVF) or gamete intrafallopian transfer (GIFT) in order to achieve multifollicular development.
KeywordsOvarian Stimulation Ovarian Hyperstimulation Syndrome Early Follicular Phase Intrauterine Insemination Exogenous Gonadotropin
Unable to display preview. Download preview PDF.
- 4.Bettendorf, G, Braendle, W, Weise, C, Poels, W (1981). Effect of gonadotropin treatment during inhibited pituitary function. In: Insler V and Bettendorf, G (eds.) “Advances in diagnosis and treatment of infertility”, p.43 (North Holland: Elsevier)Google Scholar
- 7.Lindner, Ch, Braendle, W, Bispink, L, Lichenberg, V and Bettendorf, G (1987). HMG-induced follicular maturation after blocking of endogenous pituitary gonadotropin discharge. Acta Endocrinol (Copenh.), 283 (Suppl. 114), 169Google Scholar